REDMILE GROUP, LLC – Neoleukin Therapeutics, Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$2.2M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
-37.86%
quarter
Neoleukin Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.34M | $0.64 | 3.43M | |
| Q2 2022 | share | Decrease | -0.82% | -28.5K shares | -2.97M | $1.03 | 3.43M |
| Q1 2022 | share | Decrease | -0.73% | -25.4K shares | -10.31M | $1.88 | 3.46M |
| Q4 2021 | share | Decrease | -0.47% | -16.4K shares | -8.53M | $5.1 | 3.49M |
| Q3 2021 | share | Decrease | -10.51% | -412K shares | -10.81M | $7.23 | 3.50M |
| Q2 2021 | share | Decrease | -4.82% | -198.33K shares | -14.51M | $9.23 | 3.91M |
| Q1 2021 | share | Decrease | -0.35% | -14.3K shares | -7.57M | $12.31 | 4.11M |
| Q4 2020 | share | Decrease | -0.98% | -40.81K shares | 8.18M | $14.1 | 4.13M |
| Q3 2020 | share | Increase | +3.25% | 131.47K shares | -17.01M | $12 | 4.17M |
| Q2 2020 | share | 0.00% | 0 shares | 21.09M | $16.6 | 4.04M | |
| Q1 2020 | share | Increase | +110.39% | 2.12M shares | 22.32M | $11.38 | 4.04M |
| Q4 2019 | share | Increase | 0.00% | 1.92M shares | 23.66M | $12.32 | 1.92M |